A review to determine regulatorily and reimbursement successes of studies conducted using data from Canadian patient support programs based on the real-world evidence guidelines published by Canadian drug agency and health Canada
IntroductionPatient Support Programs (PSPs) are growing globally to support early reimbursement, disease and medication dosing management. In Canada, the lack of public health support has promoted the rapid expansion of company-supported disease-specific or drug-product-specific PSPs. Data collected...
Saved in:
| Main Author: | Catherine Y. Lau |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Journal of Pharmacy & Pharmaceutical Sciences |
| Subjects: | |
| Online Access: | https://www.frontierspartnerships.org/articles/10.3389/jpps.2025.14587/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Problematizing Canadian exceptionalism
by: Laura J. Kwak
Published: (2019-01-01) -
Time-limited reimbursement and Temporary Access Process for early access to oncology treatments in Canada: a perspective based on the epcoritamab experience
by: Chakrapani Balijepalli, et al.
Published: (2025-04-01) -
Canadian Scholarship on North America
by: Laura Macdonald
Published: (2010-03-01) -
The Canadian Reconciliation Barometer: a rigorous tool for tracking reconciliation in Canada
by: K. B. Starzyk, et al.
Published: (2024-12-01) -
Two levels of Foresight in Canada
by: Mikhail Salazkin, et al.
Published: (2007-06-01)